One notable change from the last released updated bill was the removal of the solidarity levy of 2 b...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe Innovative Medicines Fund launched on 7th June 2022 The Innovative Medicines Fund (IMF), which w...
Read moreThrough the new fund, £340 million is to be made available to purchase promising, potentially life-...
Read moreThe High Authority for Health (HAS) and National Agency for Drug Safety (ANSM) have published a prel...
Read moreWith respects to pricing and reimbursement, the societies reportedly call for the criteria that led ...
Read moreDurvalumab was previously made available to NHS patients in 2019 through the Cancer Drugs Fund (CDF)...
Read moreSpending by the main health insurance fund (Caisse nationale d’assurance maladie, CNAM) on medicin...
Read moreEUCOPE notes that “while these proposals don’t necessarily represent the final options included ...
Read moreAccording to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...
Read more